Press What’s news at AbelsonTaylor Group
Select category
Moving Into 2024
Applying his background in pharmacology, Jeff Berg, President of AbelsonTaylor Group, discusses a particularly exciting use of AI in drug discovery that is tackling one of biology’s biggest challenges – predicting the 3D shape of proteins and designing them from scratch. Read more at https://www.pharmalive.com/healthcare-agency-roundtable-2024-moving-into-2025/
Media Contact:
Recent Posts
Irene Westcott Joins AbelsonTaylor Group as VP, Creative Director
AbelsonTaylor Group today announced that Irene Westcott has joined the agency as Vice President, Creative Director. A seasoned copy-led creative...
Read Press Read more Irene Westcott Joins AbelsonTaylor Group as VP, Creative DirectorA Powerful Combination for Giving Back
The group was formed during the COVID pandemic to restore wooded areas of a public golf course that had become overrun with invasive species. What began as occasional weekend volunteering evolved into a leadership role, organizing work sessions and supporting long-term planning.
In the News Read more A Powerful Combination for Giving BackThe Power of Curiosity: What I’ve Learned on My Journey from Medicine to Marketing
In a recent MedAdNews byline, Elsa Varghese, M.D., medical strategy director at AbelsonTaylor Group, reflects on the role curiosity has...
In the News Read more The Power of Curiosity: What I’ve Learned on My Journey from Medicine to MarketingConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.